Prognosis of Elevated Serum Ferritin in Allogeneic-HCT
DOI:
https://doi.org/10.15379/2408-9877.2015.02.02.01Keywords:
Hematopoietic stem cell transplantation, Allogeneic, iron overload, Serum ferritin, Early infectious complications, Risk indexes.Abstract
Introduction: Serum ferritin was demonstrated to be a useful tool to predict the risk in patients who undergo hematopoietic stem cell transplantation (HCT). Still it is not clear if its predictive value solely represents iron overload (IO) and published results are sometimes contradictory. So the objective of present study was to determine relationship between elevated pre-HCT serum ferritin levels, morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HCT) on one side, and its correlations with various risk indexes which were developed recently to predict outcomes after allo-HCT on the other side.
Patients and Methods: In this retrospective study we have reviewed medical records of one hundred six consecutive patients (52 males and 54 females), with a median age of 32 years (range, 5 to 60), who underwent allo-HCT with unmanipulated grafts between Jan 2013 and Dec2014. We retrieved pre-allo-HCT serum ferritin levels and also calculated risk indexes before HCT. The incidence of complications and outcomes after allo-HCT was assessed. The median follow-up period was 12 (range, 4-27) months after allo-HCT.
Results: We have determined a cuttoff ferritin level of 500 ng/mL for early complications and 737 for outcomes. We found increased incidence of number of febrile neutropenic episodes (P =0.02), number of bacterial infection episodes (P =0.009), pneumonias (P =0.039), slower period of neutrophil engraftment (P=0.032), demand for multiple red blood cell (RBC) transfusions (P =0.002) within 100 days post transplantation. A significant association was found between pre-transplant ferritin concentrations and different risk indexes; European Group for Blood and Marrow Transplantation (EBMT) risk score (P=0.001), Hematopoietic cell transplantation comorbidity index (HCT-CI) (P=0.003), Pre-transplant Assessment of Mortality (PAM) score (P=0.007) and disease risk (DR) (P =0.037).
Conclusion: On the one hand we did confirmed that even moderate serum ferritin elevation is associated with increased incidence of infections, slower period to engraftment and increasing demand of RBC units transfusions, but strong correlation with pre-transplant indexes that take into account disease risk raises the question if IO is the only factor that adversely affect the outcome of HCT in patients with increased ferritin. This should be studied in prospective trials.
References
Pullarkat V. Iron overload in patients undergoing hematopoietic stem cell transplantation. Adv Hematol 2010; 2010. pii: 345756
Chow JK, Werner BG, Ruthazer R, Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis 2010; 51: e16-e23
Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA, Kokturk N. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: The role of iron overload. Bone Marrow Transplant 2010; 45: 1528-1533. http://dx.doi.org/10.1038/bmt.2009.383
Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malig-nancies. Int J Hematol 2011; 93: 368-374. http://dx.doi.org/10.1007/s12185-011-0784-0
Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011; 46: 208-216. http://dx.doi.org/10.1038/bmt.2010.108
Dadwal SS, Tegtmeier B, Liu X, Frankel P, Ito J, Forman SJ, Pullarkat V. Impact of pre-transplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation Eur J Haematol. 2014 Aug 1. doi: 10.1111/ ejh. 12421
Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Ya?ci M. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. Transplant Proc 2010; 42(5): 1841-1848. http://dx.doi.org/10.1016/j.transproceed.2009.11.049
Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 195-204. http://dx.doi.org/10.1016/j.bbmt.2008.11.012
Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allo-geneic haematopoietic stem cell transplantation. Br J Haematol 2009; 146: 310-316. http://dx.doi.org/10.1111/j.1365-2141.2009.07774.x
Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci EM, Van Lint T, et al. Prognostic impact of pretransplan-tation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica.2010; 95: 476-484. http://dx.doi.org/10.3324/haematol.2009.011429
McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multi-organ failure after bone marrow transplantation: a cohort study of 355 patients. Ann Int Med 118: 255.1993
Simone CM, Angelo M, Alexandre MA, Marta C, Luis FB, Marcio N. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood, 6 august 2009,V 114, N 6
Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK, et al. The transplant iron score as a predictor of stem cell transplant survival. J Hematol Oncol 2009; 2: 44-52. http://dx.doi.org/10.1186/1756-8722-2-44
Trottier BJ, Defor TE, Burns LJ, Defor TE, Cooley S, Majhail NS. Association of iron overload with survival and com-plications in allogeneic hematopoietic cell transplant recipients: prospective cohort study using R2-MRI measured liver iron content. Blood 2013; 122: 1678-1684. http://dx.doi.org/10.1182/blood-2013-04-499772
Armand P, Sainvil MM, Kim HT, Rhodes J, Cutler C, Ho VT, et al. Does iron overload really matter in stem cell transplantation? Am J Hematol.2012; 87: 569-572. http://dx.doi.org/10.1002/ajh.23188
Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immuno-compromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7, 2002. http://dx.doi.org/10.1086/323335
Armand P, Gibson CJ, Cutler C, Ho TV, Koreth J, Alyea EP, et al. Disease risk index for patients undergoing allogeneic stem cell transplantation.Blood, 26 JULY 2012.V 120, N 4
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood.2005; 106(8): 2912-2919. http://dx.doi.org/10.1182/blood-2005-05-2004
A Gratwohl. The EBMT risk score. Bone Marrow Transplantation 2012; 47: 749-756. http://dx.doi.org/10.1038/bmt.2011.110
Parimon T, Au DH Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med. 2006 Mar 21; 144 (6): 407-14. http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00007
Gratwohl A, Hermans J, ApperleyJ, Arcese W, Bacigalupo A, Bandini G, et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood.1995, 86, 813-818
Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, et al. Composite end point of graft-versus-host disease-free, relapse-fre survival after allogeneic hematopoietic cell transplantation. Blood, 19 FEBRUARY 2015,V125, N 8
Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987-989. http://dx.doi.org/10.1038/sj.bmt.1703570
Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586-4588. http://dx.doi.org/10.1182/blood-2006-10-054924
Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R, et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34(6): 505-509. http://dx.doi.org/10.1038/sj.bmt.1704628
Lee JW, Kang HJ, Kim EK, Kim H, Shin Y, Ahn HS. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2009; 44: 793-797. http://dx.doi.org/10.1038/bmt.2009.88
Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman S.J. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant.2008; 42: 799-805. http://dx.doi.org/10.1038/bmt.2008.262
Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer. 2007; 110: 1303-1306. http://dx.doi.org/10.1002/cncr.22909
Tanaka M, Kanamori H, Matsumoto K,Tachibana T, Numata A, Ohashi K, et al. Clinical significance of pretransplant serum ferritin on the outcome of allo-geneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy. Bone Marrow Transplantation; 2 March. 2015, 1 - 7; doi: 10.1038/bmt
Douglas B. Kell and Etheresia Pretorius. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics, 2014,6, 748-773DOI: 10.1039/C3MT00347G. http://dx.doi.org/10.1039/c3mt00347g
Boelaert JR, Vandecasteele SJ, Appelberg R, Gordeuk VR. The Effect of the Host’s Iron Status on Tuberculosis. The Journal of Infectious Diseases 2007; 195: 1745-53. http://dx.doi.org/10.1086/518040
Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge forclinical medicine. Journal of medical microbiology. 2006 Mar; 55(Pt 3): 251-8. http://dx.doi.org/10.1099/jmm.0.46386-0
Pieracci FM, Barie PS. Iron and the risk of infection. Surg Infect (Larchmt). 2005; 6 Suppl 1S41-6. http://dx.doi.org/10.1089/sur.2005.6.s1-41
Mencacci A, Cenci E, Johan RB, Bucci P, Mosci P, Cristiana Fe` d’Ostiani, et al. Iron Overload Alters Innate and T Helper Cell Responses to Candida albicans in Mice. The Journal of Infectious Diseases 1997; 175: 1467-76. http://dx.doi.org/10.1086/516481
Popova MO, Volkova A, Soulaiman SE, Vavilov V, Bondarenko S, Slesarchuk O, et al. Allo-geneic hematopoietic stem cell transplantation in patients with invasive aspergillosis. BMT: Mar. 50[41st meeting of European Society of blood and marrow transplan-tation] BMT.2015/ 27. S-33, 0056.
Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Ann N Y Acad Sci 2005; 1054: 196-205. http://dx.doi.org/10.1196/annals.1345.024
Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. PMID: Curr Med Chem 2009; 16(1): 113-29. PMID: 19149565.
Ozkurt S, Acikalin MF, Temiz G, Akay OM, Soydan M. Renal hemosiderosis and rapidly progressive glomerulonephritis asso-ciated with primary hemochromatosis. Renal Failure, June 2014, Vol. 36, No. 5: Pages 814-816. http://dx.doi.org/10.3109/0886022X.2014.892391
Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion.1990 Jul-Aug; 30(6): 532-5. http://dx.doi.org/10.1046/j.1537-2995.1990.30690333485.x
Guido D’Angelo. Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res2013; 48: 10-5. http://dx.doi.org/10.5045/br.2013.48.1.10
Tbahriti HF, Bouchenak M, Mekki K. Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol. 2013 May 6; 2(2): 31-7. http://dx.doi.org/10.5527/wjn.v2.i2.31
Downloads
Published
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .